Skip to main content

Published locations for Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients

User login

  • Reset your password
  • /content/adjuvant-capecitabine-adds-no-advantage-bisphosphonate-elderly-breast-cancer-patients
  • /familypracticenews/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate
  • /internalmedicinenews/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate
  • /obgynnews/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate-elderly
  • /oncologypractice/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate
  • /obgyn/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate-elderly-breast
  • /hematology-oncology/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate
  • /internalmedicine/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate
  • /familymedicine/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate-elderly
  • /breast-cancer-icymi/article/89365/oncology/adjuvant-capecitabine-adds-no-advantage-bisphosphonate